SCHEMBL2961979

SCHEMBL2961979

CCC(C)[CH]C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5663155 0.77 TSHR (0.32)
SCHEMBL27457767 0.75
SCHEMBL11314725 0.73
SCHEMBL11046280 0.73
SCHEMBL4924526 0.73
SCHEMBL11146118 0.73
SCHEMBL4420858 0.71 TSHR (0.32)
2-Methylbutanal SCHEMBL4507667 0.69 TSHR (0.41)
SCHEMBL8070462 0.69
SCHEMBL9776319 0.67 LMNA (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7767840-B2 Organometallic compounds ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2010-08-03 US claimed
EP-1756271-B1 METHODS FOR OBTAINING OPTICALLY ACTIVE EPOXIDES AND VICINAL DIOLS FROM 2,2-DISUBSTITUTED EPOXIDES CSIR (ZA) 2015-12-09 EP disclosed
EP-1753862-B1 METHODS FOR OBTAINING OPTICALLY ACTIVE EPOXIDES AND VICINAL DIOLS FROM MESO-EPOXIDES CSIR (ZA) 2015-11-18 EP disclosed
EP-2842948-A1 Novel compounds and compositions and methods of use Ardea Biosciences, Inc. (US) 2015-03-04 EP disclosed
EP-2240443-B1 PROLINE ANALOGS AS LIGANDS FOR CANNABINOID RECEPTORS FOR THE TREATMENT OF PAIN PURDUE PHARMA LP (US) 2013-11-20 EP disclosed
EP-2583963-A1 Proline analogs as ligands for cannabinoid receptors for the treatment of pain Purdue Pharma L.P. (US) 2013-04-24 EP disclosed
US-8084612-B2 Proline analogs as ligands for cannabinoid receptors PURDUE PHARMA L.P. (US) 2011-12-27 US disclosed
EP-2240443-A1 PROLINE ANALOGS AS LIGANDS FOR CANNABINOID RECEPTORS FOR THE TREATMENT OF PAIN Purdue Pharma LP (US) 2010-10-20 EP disclosed
US-20090291947-A1 PROLINE ANALOGS AS LIGANDS FOR CANNABINOID RECEPTORS PURDUE PHARMA L.P. (US) 2009-11-26 US disclosed
WO-2009087564-A1 PROLINE ANALOGS AS LIGANDS FOR CANNABINOID RECEPTORS FOR THE TREATMENT OF PAIN PURDUE PHARMA L.P. (DE) 2009-07-16 WO disclosed
WO-2005100587-A2 METHODS FOR OBTAINING OPTICALLY ACTIVE EPOXIDES AND VICINAL DIOLS FROM 2,2-DISUBSTITUTED EPOXIDES CSIR (ZA) 2005-10-27 WO disclosed
EP-1268499-A1 METHOD FOR POLYMERIZING POLAR SUBSTITUTED CYCLOALKENES Bayer Aktiengesellschaft (DE) 2003-01-02 EP disclosed
US-6495688-B2 USED AS CORTICOTROPIN-RELEASING FACTOR (CRF) ANTAGONISTS, IN THERAPY AND DIAGNOSIS OF STRESS RELATED DISORDERS SUCH AS POST TRAUMATIC STRESS DISORDER (PTSD) AS WELL AS DEPRESSION, HEADACHE AND ANXIETY NEUROGEN CORPORATION 2002-12-17 US disclosed
US-20020065290-A1 Novel deazapurine derivatives: a new class of CRF1 specific ligands NEUROGEN CORPORATION 2002-05-30 US disclosed
WO-2001072760-A1 METHOD FOR POLYMERIZING POLAR SUBSTITUTED CYCLOALKENES BAYER AKTIENGESELLSCHAFT (DE) 2001-10-04 WO disclosed
EP-0915935-B1 4,7-DICHLORORHODAMINE DYES PERKIN ELMER CORP (US) 2001-03-07 EP disclosed
US-6020481-A FLUORESCENT LABELING REAGENTS; DIDEOXY POLYNUCLEOTIDE SEQUENCING AND FRAGMENT ANALYSIS METHODS. THE PERKIN-ELMER CORPORATION (US) 2000-02-01 US disclosed
US-5821356-A FOR PRIMER EXTENSION THE PERKIN ELMER CORPORATION (US) 1998-10-13 US disclosed
EP-0241735-A2 Acyloxythiophene carbon amide BAYER AG (DE) 1987-10-21 EP disclosed
EP-0207355-A1 Alkoxycarbonyl-substituted hydroxythiophene carboxamides BAYER AG (DE) 1987-01-07 EP disclosed